10Elms LLP’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
111,263
+44,729
+67% +$933K 0.98% 31
2026
Q1
$1.39M Buy
66,534
+44,334
+200% +$936K 0.88% 32
2025
Q4
$470K Buy
22,200
+1,800
+9% +$38.1K 0.43% 47
2025
Q3
$433K Buy
20,400
+7,800
+62% +$164K 0.39% 52
2025
Q2
$265K Buy
12,600
+5,500
+77% +$114K 0.25% 65
2025
Q1
$147K Buy
7,100
+5,100
+255% +$105K 0.15% 92
2024
Q4
$40.7K Buy
+2,000
New +$41.4K 0.04% 241

Other funds holding IBDW

10Elms LLP's IBDW Position: Q2 2026 in Review

10Elms LLP increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 67% in Q2 2026, buying an estimated $933K and bringing the position to 111,263 shares worth $2.32M. The position accounts for 0.98% of the portfolio, ranked #31.

10Elms LLP first reported a position in IBDW in Q4 2024 and has held it in 7 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • 10Elms LLP held 111,263 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $2.32M as of Q2 2026.
  • 10Elms LLP bought 44,729 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $933K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.98% of 10Elms LLP's portfolio in Q2 2026, its #31 holding.
  • 10Elms LLP first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.